Acorda Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965
官方登记数据
0位关注者
1995成立于
关于 Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija and Ampyra (dalfampridine) in the United States.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965
成立1995
法律形式C Corporation
状态营业中
专利424 项专利
THERAPEUTIC DOSING OF A NEUREGULIN OR A SUBSEQUENCE THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILUREMX384378B · 2025
SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINEEP3355865B1 · 2024
关键数据
法律信息
| 法定名称 | Acorda Therapeutics, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1008848在 SEC EDGAR 上查看 ↗ |
| EIN | 13-3831168 |
| 行业代码(SIC) | 2836 |
| 注册地址 | TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026